Display options
Share it on

Epidemiol Psychiatr Sci. 2014 Sep;23(3):231-3. doi: 10.1017/S2045796014000286. Epub 2014 May 01.

Autism spectrum disorders: weighing the risk of SSRI exposure in pregnancy.

Epidemiology and psychiatric sciences

G Ostuzzi, C Barbui

Affiliations

  1. Department of Public Health and Community Medicine, Section of Psychiatry,University of Verona,Verona,Italy.

PMID: 24786563 PMCID: PMC6998250 DOI: 10.1017/S2045796014000286

Abstract

A possible link between prenatal exposure to the selective serotonin reuptake inhibitors (SSRIs) and development of autism spectrum disorders (ASDs), previously suggested by two case-control studies, was not confirmed by a recent cohort study that followed for 5-10 years more than 600,000 births. However, this study failed to demonstrate that SSRI exposure during pregnancy is safe in terms of child development outcomes, as an increased risk of ASDs cannot be completely ruled out. In the present article, the main strengths and weaknesses of this study are briefly analysed, including a possibility of confounding by indication.

References

  1. Epidemiol Psychiatr Sci. 2013 Dec;22(4):307-8 - PubMed
  2. Am J Epidemiol. 1999 Jun 1;149(11):981-3 - PubMed
  3. Arch Gen Psychiatry. 2011 Nov;68(11):1104-12 - PubMed
  4. Clin Psychol Rev. 2010 Aug;30(6):733-48 - PubMed
  5. JAMA Psychiatry. 2013 Apr;70(4):436-43 - PubMed
  6. N Engl J Med. 2013 Dec 19;369(25):2406-15 - PubMed
  7. J Am Acad Child Adolesc Psychiatry. 2013 Apr;52(4):401-413.e8 - PubMed
  8. BMJ. 2013 Apr 19;346:f2059 - PubMed
  9. Autism Res Treat. 2011;2011:395190 - PubMed
  10. J Clin Psychiatry. 2013 Apr;74(4):e321-41 - PubMed

Publication Types